DK0910353T3 - Transdermal afgivelse af basiske lægemidler ved anvendelse af ikke-polære adhæsive systemer og syreoplösende midler - Google Patents
Transdermal afgivelse af basiske lægemidler ved anvendelse af ikke-polære adhæsive systemer og syreoplösende midlerInfo
- Publication number
- DK0910353T3 DK0910353T3 DK98908760T DK98908760T DK0910353T3 DK 0910353 T3 DK0910353 T3 DK 0910353T3 DK 98908760 T DK98908760 T DK 98908760T DK 98908760 T DK98908760 T DK 98908760T DK 0910353 T3 DK0910353 T3 DK 0910353T3
- Authority
- DK
- Denmark
- Prior art keywords
- basic drugs
- transdermal delivery
- adhesive systems
- acid dissolving
- dissolving agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/808,211 US5879701A (en) | 1997-02-28 | 1997-02-28 | Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
PCT/US1998/003832 WO1998037870A1 (en) | 1997-02-28 | 1998-02-27 | Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
EP98908760A EP0910353B1 (de) | 1997-02-28 | 1998-02-27 | Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0910353T3 true DK0910353T3 (da) | 2004-11-22 |
Family
ID=25198190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98908760T DK0910353T3 (da) | 1997-02-28 | 1998-02-27 | Transdermal afgivelse af basiske lægemidler ved anvendelse af ikke-polære adhæsive systemer og syreoplösende midler |
Country Status (11)
Country | Link |
---|---|
US (1) | US5879701A (de) |
EP (1) | EP0910353B1 (de) |
JP (1) | JP2000509734A (de) |
AT (1) | ATE271381T1 (de) |
AU (1) | AU6670998A (de) |
CA (1) | CA2252772C (de) |
DE (1) | DE69825116T2 (de) |
DK (1) | DK0910353T3 (de) |
ES (1) | ES2226102T3 (de) |
PT (1) | PT910353E (de) |
WO (1) | WO1998037870A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
US6294188B1 (en) | 1998-07-09 | 2001-09-25 | Aviana Biopharm Inc. | Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women |
US6280763B1 (en) | 1999-05-10 | 2001-08-28 | Pierce Management, Llc | Apparatus and method for transdermal delivery of bupropion |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
FR2814368B1 (fr) * | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
US20020198215A1 (en) * | 2000-10-23 | 2002-12-26 | Lino Tavares | Terazosin transdermal device and methods |
EP1335689B1 (de) | 2000-10-23 | 2010-03-17 | Euro-Celtique S.A. | Transdermales system zur verabreichung von loratadin und dessen verwendung |
US7018649B2 (en) * | 2000-10-23 | 2006-03-28 | Euro-Celtique, S.A. | Felodipine transdermal device and methods |
US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
US20050113510A1 (en) * | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US8840918B2 (en) * | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
CA2445086C (en) | 2001-05-01 | 2008-04-08 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions |
WO2002087642A2 (en) * | 2001-05-01 | 2002-11-07 | A.V. Topchiev Institute Of Petrochemical Synthesis | Two-phase, water-absorbent bioadhesive composition |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8541021B2 (en) * | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US20030027793A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal treatment of parkinson's disease |
US20030026830A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
US8496960B2 (en) * | 2001-10-23 | 2013-07-30 | Purdue Pharma L.P. | Terazosin transdermal device and methods |
US20030199584A1 (en) * | 2002-04-11 | 2003-10-23 | Ahluwalia Gurpreet S. | Reduction of hair growth |
US20040048779A1 (en) * | 2002-05-06 | 2004-03-11 | Erwin Schollmayer | Use of rotigotine for treating the restless leg syndrome |
DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
US8211462B2 (en) * | 2002-07-30 | 2012-07-03 | Ucb Pharma Gmbh | Hot-melt TTS for administering rotigotine |
US8246979B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
CA2496798A1 (en) * | 2002-08-30 | 2004-03-11 | Alza Corporation | Embossable and writable multilaminate backing construction |
DK1426049T3 (da) * | 2002-12-02 | 2005-08-22 | Sanol Arznei Schwarz Gmbh | Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom |
DE10261696A1 (de) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
US20050096311A1 (en) * | 2003-10-30 | 2005-05-05 | Cns Response | Compositions and methods for treatment of nervous system disorders |
RU2380092C2 (ru) | 2004-01-30 | 2010-01-27 | Кориум Интернэшнл, Инк. | Быстро растворяющаяся пленка для доставки активного агента |
EP1791575B1 (de) | 2004-08-05 | 2014-10-08 | Corium International, Inc. | Klebstoffzusammensetzung |
US8252320B2 (en) | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
EP1814531B1 (de) | 2004-10-21 | 2010-06-16 | Durect Corporation | Transdermale verabreichungssysteme |
JP5096149B2 (ja) * | 2005-08-22 | 2012-12-12 | 久光製薬株式会社 | 外用剤 |
DE102006026060B4 (de) * | 2006-01-12 | 2013-01-31 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme |
US20080044462A1 (en) * | 2006-04-06 | 2008-02-21 | Collegium Pharmaceutical, Inc. Delaware | Stabilized transdermal bupropion preparations |
WO2007119656A1 (ja) * | 2006-04-11 | 2007-10-25 | Nichiban Co., Ltd. | タムスロシン含有経皮吸収型製剤 |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
WO2008115224A2 (en) * | 2007-03-20 | 2008-09-25 | Bayer Healthcare Llc | Method of analyzing an analyte |
EP1987815A1 (de) * | 2007-05-04 | 2008-11-05 | Schwarz Pharma Ag | Im Mund-Nasen-Rachenraum verabreichbare pharmazeutische Zusammensetzungen enthaltend Dopaminagonisten zur Vorbeugung und/oder Behandlung von unruhigen Gliedmassen |
EP2201941A1 (de) * | 2008-12-29 | 2010-06-30 | UCB Pharma GmbH | Pflaster-Herstellungstechnologie |
US8784879B2 (en) * | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
US9072682B2 (en) | 2012-12-31 | 2015-07-07 | Mylan Inc. | Transdermal dosage form for low-melting point active agent |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61178915A (ja) * | 1985-02-04 | 1986-08-11 | Kotobuki Seiyaku Kk | 血圧降下用経皮吸収剤 |
US4915950A (en) * | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5262165A (en) * | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
GB9016056D0 (en) * | 1990-07-21 | 1990-09-05 | Chatfield Pharmaceuticals Limi | Transdermal medicine delivery devices |
US5198223A (en) * | 1990-10-29 | 1993-03-30 | Alza Corporation | Transdermal formulations, methods and devices |
US5633009A (en) * | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
US5232702A (en) * | 1991-07-22 | 1993-08-03 | Dow Corning Corporation | Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices |
GB9118028D0 (en) * | 1991-08-21 | 1991-10-09 | Secr Defence Brit | Improved transdrmal formulations |
CA2115840A1 (en) * | 1991-08-27 | 1993-03-04 | Tsung-Min Hsu | Transdermal formulation for administering prazosin |
FR2694495B1 (fr) * | 1992-08-05 | 1994-09-23 | Synthelabo | Préparation pharmaceutique transdermique contenant de l'alfuzosine. |
US5503843A (en) * | 1994-04-22 | 1996-04-02 | Flora Inc. | Transdermal delivery of alpha adrenoceptor blocking agents |
US5770221A (en) * | 1994-05-18 | 1998-06-23 | Hisamitsu Pharmaceutical Co., Inc. | Formulation for percutaneous administration for treating disturbance in micturition |
US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
-
1997
- 1997-02-28 US US08/808,211 patent/US5879701A/en not_active Expired - Lifetime
-
1998
- 1998-02-27 DK DK98908760T patent/DK0910353T3/da active
- 1998-02-27 ES ES98908760T patent/ES2226102T3/es not_active Expired - Lifetime
- 1998-02-27 WO PCT/US1998/003832 patent/WO1998037870A1/en active IP Right Grant
- 1998-02-27 CA CA002252772A patent/CA2252772C/en not_active Expired - Lifetime
- 1998-02-27 PT PT98908760T patent/PT910353E/pt unknown
- 1998-02-27 JP JP10537871A patent/JP2000509734A/ja not_active Ceased
- 1998-02-27 DE DE69825116T patent/DE69825116T2/de not_active Expired - Lifetime
- 1998-02-27 AU AU66709/98A patent/AU6670998A/en not_active Abandoned
- 1998-02-27 EP EP98908760A patent/EP0910353B1/de not_active Expired - Lifetime
- 1998-02-27 AT AT98908760T patent/ATE271381T1/de active
Also Published As
Publication number | Publication date |
---|---|
EP0910353A1 (de) | 1999-04-28 |
AU6670998A (en) | 1998-09-18 |
CA2252772A1 (en) | 1998-09-03 |
US5879701A (en) | 1999-03-09 |
CA2252772C (en) | 2002-04-23 |
JP2000509734A (ja) | 2000-08-02 |
EP0910353B1 (de) | 2004-07-21 |
PT910353E (pt) | 2004-11-30 |
ES2226102T3 (es) | 2005-03-16 |
ATE271381T1 (de) | 2004-08-15 |
WO1998037870A1 (en) | 1998-09-03 |
DE69825116T2 (de) | 2005-08-04 |
DE69825116D1 (de) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0910353T3 (da) | Transdermal afgivelse af basiske lægemidler ved anvendelse af ikke-polære adhæsive systemer og syreoplösende midler | |
DK0993831T3 (da) | Forbindelser og præparater til tilförsel af aktive stoffer | |
DK0693924T3 (da) | Fremgangsmåde til (in vivo)-levering af biologiske materialer og sammensætninger, der er egnede dertil | |
ATE223232T1 (de) | Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen | |
DE69031309D1 (de) | Zusammensetzung zur steigerung der hautdurchlässigkeit | |
RS49803B (sr) | Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa | |
PA8575701A1 (es) | Preparaciones acidas de insulina con estabilidad mejorada | |
CO4940469A1 (es) | Composicion oral de estabilidad mejorada que comprende un derivado de indolinona y una mezcla de gliceridos o esteres de polietilenglicol | |
MXPA04003569A (es) | Mezclas bifasicas de glp-1 e insulina. | |
DK1033981T3 (da) | Formuleringer og fremgangsmåder til nedsættelse af antineoplastiske midlers toksicitet | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
DK0758248T3 (da) | Formuleringer til faktor IX | |
MXPA05002814A (es) | Formulacion para agentes lipofilicos. | |
MXPA05003591A (es) | Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos. | |
ATE270557T1 (de) | Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen | |
PL338335A1 (en) | Pharmaceutic composition in the of self-emulsifiable formulation of lipophilic compounds | |
AP1424A (en) | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. | |
ATE345775T1 (de) | Zusammensetzungen zur verabreichung von arzneimittelkombinationen | |
DK0971717T3 (da) | Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler | |
TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
TR199902034T2 (xx) | Haricen kullan�m i�in nimes�lid jel sistemleri. | |
HUP0200055A2 (hu) | 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények | |
ES2192036T3 (es) | Agentes anti-tumorales. | |
ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
HRP20000781B1 (en) | Effervescent preparations |